Literature DB >> 9769279

Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study.

M M Pizzichini1, E Pizzichini, A Efthimiadis, A J Chauhan, S L Johnston, P Hussack, J Mahony, J Dolovich, F E Hargreave.   

Abstract

We examined the feasibility of using induced sputum to evaluate the airway inflammatory response to natural acute respiratory virus infections. We recruited eight asthmatics and nine healthy subjects on Day 4 of a cold. Viral infection was confirmed in six of the asthmatics (influenza A or B) and six of the healthy subjects (influenza A, rhinovirus, adenovirus, respiratory syncytial virus, and coronavirus). In the subjects with confirmed virus infection, five of the asthmatics had an objective exacerbation of asthma during the cold. Their sputum on Day 4 showed a high median total cell count of 19.7 x 10(6) cells/ml with a modest neutrophilia (58. 5%) and high levels of interleukin-8 (IL-8) (16,000 pg/ml), eosinophilic cationic protein (ECP) (1,880 microgram/L) and very high levels of fibrinogen (250 mg/L). In contrast, the proportion (1.3%) and absolute number of eosinophils was low. IL-2 levels were within the normal range, whereas IL-5 and interferon gamma were under the limit of detection of the assays. In the healthy subjects with a confirmed virus infection the sputum findings were qualitatively similar but significantly less prominent. Sputum IL-8 on Day 4 was strongly correlated with neutrophils (rs = 0.8, p < 0.001). This correlation was also significant when each group was analyzed separately. On Day 21 there was a fall in the absolute number of neutrophils and in ECP and fibrinogen levels in both groups. Similar results were found in the two asthmatic and three healthy subjects with a cold of comparable severity but in whom viral infection was not confirmed. We conclude that induced sputum examination can be used to study the effects of natural colds and influenza on the airways of the lungs. The results also suggest that natural colds, on Day 4, cause neutrophilic lower airway inflammation that is greater in asthmatics than in healthy subjects. The greater inflammatory response in asthmatics may be due to the changes associated with trivial eosinophilia or to the different viruses involved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9769279     DOI: 10.1164/ajrccm.158.4.9712082

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  64 in total

Review 1.  Written action plans for asthma: an evidence-based review of the key components.

Authors:  P G Gibson; H Powell
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

2.  Rhinovirus infection of allergen-sensitized and -challenged mice induces eotaxin release from functionally polarized macrophages.

Authors:  Deepti R Nagarkar; Emily R Bowman; Dina Schneider; Qiong Wang; Jee Shim; Ying Zhao; Marisa J Linn; Christina L McHenry; Babina Gosangi; J Kelley Bentley; Wan C Tsai; Umadevi S Sajjan; Nicholas W Lukacs; Marc B Hershenson
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

3.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.

Authors:  A Bhowmik; T A Seemungal; R J Sapsford; J A Wedzicha
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

4.  Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation.

Authors:  Loren C Denlinger; Ron L Sorkness; Wai-Ming Lee; Michael D Evans; Michele J Wolff; Sameer K Mathur; Gina M Crisafi; Katie L Gaworski; Tressa E Pappas; Rose F Vrtis; Elizabeth A Kelly; James E Gern; Nizar N Jarjour
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

5.  Cough, airway inflammation, and mild asthma exacerbation.

Authors:  A B Chang; V A Harrhy; J Simpson; I B Masters; P G Gibson
Journal:  Arch Dis Child       Date:  2002-04       Impact factor: 3.791

6.  A mechanistic role for type III IFN-λ1 in asthma exacerbations mediated by human rhinoviruses.

Authors:  E Kathryn Miller; Johanna Zea Hernandez; Vera Wimmenauer; Bryan E Shepherd; Diego Hijano; Romina Libster; M Elina Serra; Niranjan Bhat; Juan P Batalle; Yassir Mohamed; Andrea Reynaldi; Andrea Rodriguez; Monica Otello; Nestor Pisapia; Jimena Bugna; Miguel Bellabarba; David Kraft; Silvina Coviello; F Martin Ferolla; Aaron Chen; Stephanie J London; George K Siberry; John V Williams; Fernando P Polack
Journal:  Am J Respir Crit Care Med       Date:  2011-12-01       Impact factor: 21.405

7.  Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice.

Authors:  Dawn C Newcomb; Umadevi S Sajjan; Deepti R Nagarkar; Qiong Wang; Suparna Nanua; Ying Zhou; Christina L McHenry; Kenneth T Hennrick; Wan C Tsai; J Kelley Bentley; Nicholas W Lukacs; Sebastian L Johnston; Marc B Hershenson
Journal:  Am J Respir Crit Care Med       Date:  2008-02-14       Impact factor: 21.405

8.  Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production.

Authors:  Simon D Message; Vasile Laza-Stanca; Patrick Mallia; Hayley L Parker; Jie Zhu; Tatiana Kebadze; Marco Contoli; Gwen Sanderson; Onn M Kon; Alberto Papi; Peter K Jeffery; Luminita A Stanciu; Sebastian L Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

9.  Predicting worsening asthma control following the common cold.

Authors:  M J Walter; M Castro; S J Kunselman; V M Chinchilli; M Reno; T P Ramkumar; P C Avila; H A Boushey; B T Ameredes; E R Bleecker; W J Calhoun; R M Cherniack; T J Craig; L C Denlinger; E Israel; J V Fahy; N N Jarjour; M Kraft; S C Lazarus; R F Lemanske; R J Martin; S P Peters; J W Ramsdell; C A Sorkness; E R Sutherland; S J Szefler; S I Wasserman; M E Wechsler
Journal:  Eur Respir J       Date:  2008-09-03       Impact factor: 16.671

10.  CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection.

Authors:  Deepti R Nagarkar; Qiong Wang; Jee Shim; Ying Zhao; Wan C Tsai; Nicholas W Lukacs; Uma Sajjan; Marc B Hershenson
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.